Merck & Co., Inc. ($MRK)
Filing Information
| Accession Number | 0000310158-26-000046 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 9, 2026 |
| Document Date | Feb 9, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
364,719
Total Value
$28,971,380.82
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, General Counsel | Common Stock | โ | Feb 9, 2026 | Exercise/Conversion | 25,946 | $119.15 | $3,091,522.98 | 94,862 | Direct | โ | View Details | |
EVP, General Counsel | Common Stock | โ | Feb 9, 2026 | Sale | 25,946 | $119.15 | $3,091,522.98 | 68,916 | Direct | โ | View Details | |
EVP, General Counsel | Common Stock | โ | Feb 9, 2026 | Exercise/Conversion | 56,792 | $119.15 | $6,766,891.74 | 125,708 | Direct | โ | View Details | |
EVP, General Counsel | Common Stock | โ | Feb 9, 2026 | Sale | 56,792 | $119.15 | $6,766,891.74 | 68,916 | Direct | โ | View Details | |
EVP, General Counsel | Common Stock | โ | Feb 9, 2026 | Exercise/Conversion | 38,835 | $119.15 | $4,627,275.69 | 107,751 | Direct | โ | View Details | |
EVP, General Counsel | Common Stock | โ | Feb 9, 2026 | Sale | 38,835 | $119.15 | $4,627,275.69 | 68,916 | Direct | โ | View Details | |
EVP, General Counsel | Stock Option (Right to Buy) | Derivative | Feb 9, 2026 | Exercise/Conversion | 25,946 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
EVP, General Counsel | Stock Option (Right to Buy) | Derivative | Feb 9, 2026 | Exercise/Conversion | 56,792 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
EVP, General Counsel | Stock Option (Right to Buy) | Derivative | Feb 9, 2026 | Exercise/Conversion | 38,835 | $0.00 | $0.00 | 0 | Direct | โ | View Details |